Perales MA, Awan FT, Boumendil A, Patel J, et al. Outcomes of Allogeneic HCT in Hodgkin Lymphoma in the Era of Checkpoint Inhibitors: A Joint CIBMTR and EBMT Analysis. Blood 2025 Jul 7:blood.2024027197. doi: 10.1182/blood.2024027197.
PMID: 40623049